Why Keeler Accutome B-Scan Plus still matters in busy eye clinics

Halma’s Keeler Accutome B-Scan Plus is not the flashiest device in an ophthalmology practice, but its detailed ultrasound images of the eye become crucial exactly when the view turns cloudy. What the compact system offers, where it convinces, and where it shows its age.

Reviewed: ad hoc news Software & Services desk. Edited and checked on 2026-06-18, 11:18. Details in the imprint.

When the pupil is dilated but the fundus stays stubbornly hidden behind cataract or vitreous hemorrhage, the Keeler Accutome B-Scan Plus becomes the quiet hero in the darkened exam room. The compact ultrasound console sits beside the slit lamp, ready to sketch the hidden retina in crisp grayscale. It is a workhorse tool rather than a showpiece - and that is precisely its appeal.

What the B-Scan actually does

The Keeler Accutome B-Scan Plus is a dedicated ophthalmic ultrasound system designed to visualize the posterior segment when optical methods fail because of media opacity. It produces two-dimensional cross-sectional images of the globe that help detect retinal detachments, tumors, and vitreous pathology.

The probe runs typically at 10 MHz, a frequency that balances penetration and resolution for the eye’s deep structures. With standardized gain settings and presets, the device aims to give repeatable images across patients and sessions, limiting guesswork for clinicians who perform scans only occasionally.

Everyday handling in the clinic

In routine use, the B-Scan Plus sits either as a small console on a trolley or integrated with a PC, with the probe and footswitch dangling ready next to the exam chair. The gel is cold, the room lights are down, and the operator watches the live echo shimmer as the patient looks up, down, left, and right.

The software allows freezing, measuring, and storing still images and short cine clips for documentation and teleconsultation. For clinicians, that means a subtle but important workflow benefit: findings can be pulled into reports and shared with surgical colleagues without repeating the exam.

Image quality and features

Compared with older analog B-scan units, the Keeler Accutome B-Scan Plus delivers a noticeably sharper, less noisy image that makes thin retinal membranes or choroidal masses easier to pick out. Many ophthalmologists value the device’s dynamic range, which lets them differentiate subtle reflectivity differences between serous and solid lesions.

The system supports zoom, gain adjustment, and measurement tools directly on screen, so the operator can fine-tune the view during the exam. On the flip side, the monochrome interface and somewhat dated UI graphics show that this is an evolution of a long-standing platform rather than a ground-up reinvention.

How it fits into Halma’s portfolio

Keeler, part of Halma’s Healthcare sector, focuses on ophthalmic instruments, from retinoscopes to slit lamps and imaging systems. The Accutome B-Scan Plus sits alongside A-scan biometry and pachymetry devices, forming a compact ultrasound suite for eye care professionals.

Halma’s healthcare businesses together target structural trends like aging populations and growing demand for eye care in emerging markets. In its latest full-year report, Halma highlighted healthcare as one of the groups delivering organic revenue growth, underlining the strategic importance of specialist devices like the B-Scan Plus.

Pricing, availability, and target users

The Keeler Accutome B-Scan Plus is marketed primarily to ophthalmologists, retinal specialists, and hospital eye departments, often sold through medical distributors rather than direct online channels. In Europe and North America, it typically appears as part of turnkey diagnostic packages that bundle ultrasound with chairs and slit lamps.

Halma does not publish a list price, but dealers usually position the B-Scan Plus in the mid-to-upper segment of dedicated ophthalmic ultrasound units. The target group is therefore practices and clinics that run enough posterior-segment cases to justify specialist hardware, yet still value compact, cart-based solutions over large multimodal platforms.

Where it shines, where it shows limits

The system’s strongest card is reliability: it usually just works, exam after exam, with consistent images and simple controls that nurses and technicians can learn quickly. For small teams, that predictability matters more than bleeding-edge features or fancy touch interfaces.

However, the B-Scan Plus no longer feels ultra-modern in an era of slick touchscreen consoles and AI-assisted image analysis. There is no automated lesion classification or cloud-native reporting baked in, and integration into hospital PACS often requires additional IT effort or third-party solutions.

Company and stock context

Keeler’s ultrasound devices are one tile in Halma’s broader safety and health mosaic, which spans gas detection, fire protection, environmental monitoring, and medical technology. That diversity has historically given the group a reputation for steady compounding rather than headline-grabbing swings.

Shares of Halma (GB0004052071) trade on the London Stock Exchange, where the company is part of the FTSE 100 index.

Key facts about the Keeler Accutome B-Scan Plus

• Product: Keeler Accutome B-Scan Plus
• Manufacturer: Halma plc
• Category: Software/Service/Subscription (ophthalmic imaging system)
• Launch: Long-standing product line, ongoing updates
• RRP / Price: Typically mid-to-upper range among dedicated ophthalmic B-scan units (dealer pricing, not officially disclosed)
• Availability: Distributed via Keeler and medical equipment dealers in North America, Europe, and other key ophthalmology markets
• Target group: Ophthalmologists, retinal specialists, and hospital eye clinics needing posterior segment imaging when media are opaque
• Highlight / USP: Reliable, clinic-proven B-scan ultrasound with clear ocular imaging and straightforward workflow for everyday use

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.